Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 264

Sort by

Sort Order Select

Journal Articles

Development of CD38 CAR Engineered Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (PNK-CAR38) As Allogeneic Cancer Immunotherapy

Srinivas Somanchi, PhD, Xuan Guo, PhD, Shuyang He, PhD, Rohit Mathur, PhD, Andrea Difiglia, BS, Hemlata Rana, MS, Weifang Ling, PhD, James Edinger, PhD, Gunnar F. Kaufmann, PhD, Jerome B. Zeldis, MD PhD, Henry Ji, PhD, Robert Hariri, MD PhD, Xiaokui Zhang, PhD

Blood (2019) 134 (Supplement_1): 2070.

https://doi.org/10.1182/blood-2019-129539

Published: 2019

Journal Articles

FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial

Blood (2019) 134 (Supplement_1): 4434.

https://doi.org/10.1182/blood-2019-130584

Published: 2019

Journal Articles

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Frederick Fasslrinner, MD, Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, PhD, Liliana Raquel Loureiro, PhD, Marc Schmitz, MD, Gundram Jung, MD, Martin Bornhaeuser, MD, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5614.

https://doi.org/10.1182/blood-2019-124279

Published: 2019

Journal Articles

CEBPA Gene Mutations Interfere with Expressions of NKG2D Ligands Ulbps in AML Cells and Modulate Their Susceptibility to NK-Mediated Lysis

Meng Liu, Limengmeng Wang, PhD, Huafang Wang, Shan Fu, He Huang, Haowen Xiao

Blood (2019) 134 (Supplement_1): 1257.

https://doi.org/10.1182/blood-2019-129899

Published: 2019

Journal Articles

Foamy Virus Based Vectors for CAR-T Cell Development

Emmanouil Simantirakis, MSc, Vassilis Atsaves, PhD, Ioannis Tsironis, BSc MSc, Margarita Gkyzi, BSc, Kostas Konstantopoulos, MD PhD, George Vassilopoulos, MD PhD

Blood (2019) 134 (Supplement_1): 4646.

https://doi.org/10.1182/blood-2019-123022

Published: 2019

Journal Articles

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications

Katherine J. Kearney, Nikoletta Pechlivani, Rhodri King, Christian Tiede, Fladia Phoenix, Ramsah Cheah, Fraser L. Macrae, Katie J. Simmons, Iain W. Manfield, Kerrie A. Smith, Benjamin E. J. Spurgeon, Khalid M. Naseem, Robert A. S. Ariens, Michael J. McPherson, Darren C. Tomlinson, Ramzi A. Ajjan

Blood (2019) 133 (11): 1233–1244.

https://doi.org/10.1182/blood-2018-06-856195

Published: 2019

Includes: Supplemental data

Journal Articles

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

Monika Herrmann, Christina Krupka, Katrin Deiser, Bettina Brauchle, Anetta Marcinek, Ana Ogrinc Wagner, Felicitas Rataj, Ralph Mocikat, Klaus H. Metzeler, Karsten Spiekermann, Sebastian Kobold, Nadja C. Fenn, Karl-Peter Hopfner, Marion Subklewe

Blood (2018) 132 (23): 2484–2494.

https://doi.org/10.1182/blood-2018-05-849802

Published: 2018

Includes: Supplemental data

Journal Articles

APRIL Is Significantly Elevated at All Stages of Multiple Myeloma (MM) and Interferes with Anti-Bcma Monoclonal Antibody-Mediated Cytolysis, Supporting the Clinical Evaluation of Bion-1301 As a Novel Therapeutic Approach in MM

Yu-Tzu Tai, PhD, John Dulos, PhD, Lars Guelen, Liang Lin, PhD, Lijie Xing, MD, Shih-Feng Cho, MD PhD, Kenneth Wen, BS, Tengteng Yu, MD, Phillip A Hsieh, Peter van Zandvoort, Bsc, Guido van de Wiel, Jos van de Crommert, Bsc, Bonny Lejeune, Hamid Namini, Hans Eenennaam, PhD, Andrea van Elsas, PhD, Paul Richardson, Nikhil Munshi, MD, Kenneth C. Anderson, MD

Blood (2018) 132 (Supplement 1): 3209.

https://doi.org/10.1182/blood-2018-99-117296

Published: 2018

Journal Articles

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Monika Herrmann, PhD, Christina Krupka, PhD, Katrin Deiser, PhD, Bettina Lindl, Ralph Mocikat, MD, Klaus H. Metzeler, MD, Karsten Spiekermann, MD, Sebastian Kobold, MD, Nadja Fenn, PhD, Karl-Peter Hopfner, PhD, Marion Subklewe, MD

Blood (2018) 132 (Supplement 1): 4069.

https://doi.org/10.1182/blood-2018-99-119624

Published: 2018

Journal Articles

Impact of Treatment on B-Cell Regeneration By Next Generation Flow Cytometry in Patients with Multiple Myeloma

Robéria Pontes, MSc, Juan Flores-Montero, Luzalba Sanoja-Flores, Noemi Puig, MD PhD, Roberto José Pessoa Magalhães, MD, Alba Corral Mateos, Anna Beatriz Salgado, Angelo Maiolino, MD, Maria-Victoria Mateos, MD PhD, Bruno Paiva, MD PhD, Elaine Sobral da Costa, PhD, Jacques JM van Dongen, Alberto Orfao, MD PhD

Blood (2018) 132 (Supplement 1): 4491.

https://doi.org/10.1182/blood-2018-99-117162

Published: 2018

Journal Articles

Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles

Christian M. Seitz, MD, Verena Kieble, cand.MD, Clara Illi, cand. MD, Selina Reiter, cand. MD, Stefan Grote, MSc, Joerg Mittelstaet, PhD, Dominik Lock, M.Sc., Andrew Kaiser, PhD, Sabine Schleicher, PhD, Rupert Handgretinger, MD PhD, Peter Lang, MD, Patrick Schlegel, MD

Blood (2018) 132 (Supplement 1): 4543.

https://doi.org/10.1182/blood-2018-99-115630

Published: 2018

Journal Articles

Anti-BCMA BiTE ® AMG 701 Potently Induces Specific T Cell Lysis of Human Multiple Myeloma (MM) Cells and Immunomodulation in the Bone Marrow Microenvironment

Shih-Feng Cho, MD PhD, Liang Lin, PhD, Lijie Xing, MD, Jiye Liu, PhD, Tengteng Yu, MD, Kenneth Wen, BS, Phillip Hsieh, Nikhil Munshi, MD, Kenneth Anderson, MD, Yu-Tzu Tai, PhD

Blood (2018) 132 (Supplement 1): 592.

https://doi.org/10.1182/blood-2018-99-118425

Published: 2018

Journal Articles

Red Blood Cell Lysis Procedure Improves the Performances of ELN Dyserythropoiesis Score Compared to Nuclear Dye Use without Lysis

Hugo Germain, Sihem Tarfi, PharmD, Nicolas Freynet, PharmD, Andrea Toma, MD PhD, Bouchra Badaoui, PharmD, Orianne Wagner Ballon, MD PhD

Blood (2018) 132 (Supplement 1): 3108.

https://doi.org/10.1182/blood-2018-99-114179

Published: 2018

Journal Articles

An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma

Lydia Lee, Benjamin Draper, Neil Chaplin, Brian Philip, Melody Chin, Daria Galas-Filipowicz, Shimobi Onuoha, Simon Thomas, Vania Baldan, Reyisa Bughda, Paul Maciocia, Eva Kokalaki, Margarida P. Neves, Dominic Patel, Manuel Rodriguez-Justo, James Francis, Kwee Yong, Martin Pule

Blood (2018) 131 (7): 746–758.

https://doi.org/10.1182/blood-2017-05-781351

Published: 2018

Includes: Supplemental data

Journal Articles

Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML

Blood (2017) 130 (Supplement 1): 2634.

https://doi.org/10.1182/blood.V130.Suppl_1.2634.2634

Published: 2017

Journal Articles

Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM

Blood (2017) 130 (Supplement 1): 742.

https://doi.org/10.1182/blood.V130.Suppl_1.742.742

Published: 2017

Journal Articles

Characterizing the Mechanism of NE and P3 Cross-Presentation in B Cell-Acute Lymphoblastic Leukemia

Selena Carmona, MS, Celine Kerros, PhD, Alexander Perakis, Anne Philip, Pariya Sukhumalchandra, Anna Sergeeva, PhD, Lisa St. John, Mao Zhang, MPH, Na Qiao, Elizabeth Mittendorf, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD

Blood (2017) 130 (Supplement 1): 3596.

https://doi.org/10.1182/blood.V130.Suppl_1.3596.3596

Published: 2017

Journal Articles

Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial

Anita Hill, MBChB (Hons), PhD, Wynne Weston-Davies, MB FRCS, Miles Nunn, PhD, Tadeusz Robak, MD PhD, Jerzy Windyga, MD, Andrzej Hellmann, MD PhD DSc, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Agniezka Piekarska, Anna Szmigielska-Kaplon, Morag Griffin, Talha Munir

Blood (2017) 130 (Supplement 1): 4747.

https://doi.org/10.1182/blood.V130.Suppl_1.4747.4747

Published: 2017

Journal Articles

Evaluation of Global Coagulation Assays in Normal and Thrombocytopenic Populations

Hui Yin Lim, MBBS, BMedSc, Patrick Leung, Vanessa Manitta, MBBS, FRACP, FRCPA, Harshal Nandurkar, MDPhD, Prahlad Ho, MBBS, FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 2323.

https://doi.org/10.1182/blood.V130.Suppl_1.2323.2323

Published: 2017

Journal Articles

Lysis of human neutrophils by community-associated methicillin-resistant Staphylococcus aureus

Mallary C. Greenlee-Wacker, Silvie Kremserová, William M. Nauseef

Blood (2017) 129 (24): 3237–3244.

https://doi.org/10.1182/blood-2017-02-766253

Published: 2017

Includes: Supplemental data

NARROW

Development of CD38 CAR Engineered Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (PNK-CAR38) As Allogeneic Cancer Immunotherapy

FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

CEBPA Gene Mutations Interfere with Expressions of NKG2D Ligands Ulbps in AML Cells and Modulate Their Susceptibility to NK-Mediated Lysis

Foamy Virus Based Vectors for CAR-T Cell Development

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

APRIL Is Significantly Elevated at All Stages of Multiple Myeloma (MM) and Interferes with Anti-Bcma Monoclonal Antibody-Mediated Cytolysis, Supporting the Clinical Evaluation of Bion-1301 As a Novel Therapeutic Approach in MM

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Impact of Treatment on B-Cell Regeneration By Next Generation Flow Cytometry in Patients with Multiple Myeloma

Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles

Anti-BCMA BiTE ® AMG 701 Potently Induces Specific T Cell Lysis of Human Multiple Myeloma (MM) Cells and Immunomodulation in the Bone Marrow Microenvironment

Red Blood Cell Lysis Procedure Improves the Performances of ELN Dyserythropoiesis Score Compared to Nuclear Dye Use without Lysis

An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma

Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML

Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM

Characterizing the Mechanism of NE and P3 Cross-Presentation in B Cell-Acute Lymphoblastic Leukemia

Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial

Evaluation of Global Coagulation Assays in Normal and Thrombocytopenic Populations

Lysis of human neutrophils by community-associated methicillin-resistant Staphylococcus aureus

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only